| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |